Reata Pharmaceuticals Inc (NASDAQ:RETA)

Delayed Data
As of Sep 30
 +0.14 / +0.56%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 43.00, with a high estimate of 76.00 and a low estimate of 27.00. The median estimate represents a +70.84% increase from the last price of 25.17.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.34%
Growthannually -3.95%


Growthquarterly 35.49%
Growthannually -72.40%
Key to the earnings and sales forecast charts.